These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29534654)

  • 1. Factors Associated with Outcomes of Pre-ART HIV Care.
    Stafford KA; Nganga LW; Tulli T; Foreit KGF
    J Int Assoc Provid AIDS Care; 2018; 17():2325958218759602. PubMed ID: 29534654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study.
    Mecha JO; Kubo EN; Nganga LW; Muiruri PN; Njagi LN; Mutisya IN; Odionyi JJ; Ilovi SC; Wambui M; Githu C; Ngethe R; Obimbo EM; Ngumi ZW
    AIDS Res Ther; 2016; 13():38. PubMed ID: 27895697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decentralization of HIV care and treatment services in Central Province, Kenya.
    Reidy WJ; Sheriff M; Wang C; Hawken M; Koech E; Elul B; Kimanga D; Abrams EJ;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):e34-40. PubMed ID: 24977728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
    Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
    Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
    Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
    PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
    McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
    AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic infection at the start of antiretroviral therapy and baseline CD4+ count less than 50 cells/mm3 are associated with poor immunological recovery.
    Tilak A; Shenoy S; Varma M; Kamath A; Tripathy A; Sori R; Saravu K
    J Basic Clin Physiol Pharmacol; 2019 Mar; 30(2):163-171. PubMed ID: 30901314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
    Nsanzimana S; Kanters S; Remera E; Forrest JI; Binagwaho A; Condo J; Mills EJ
    Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes for first-line antiretroviral therapy in India's ART program.
    Dandona R; Rewari BB; Kumar GA; Tanwar S; Kumar SG; Vishnumolakala VS; Duber HC; Gakidou E; Dandona L
    BMC Infect Dis; 2016 Oct; 16(1):555. PubMed ID: 27729025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.
    Rachlis B; Bakoyannis G; Easterbrook P; Genberg B; Braithwaite RS; Cohen CR; Bukusi EA; Kambugu A; Bwana MB; Somi GR; Geng EH; Musick B; Yiannoutsos CT; Wools-Kaloustian K; Braitstein P
    PLoS One; 2016; 11(8):e0159994. PubMed ID: 27509182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
    Ayele W; Mulugeta A; Desta A; Rabito FA
    BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
    Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
    Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-ART nutritional status and its association with mortality in adult patients enrolled on ART at Fiche Hospital in North Shoa, Oromia region, Ethiopia: a retrospective cohort study.
    Tesfamariam K; Baraki N; Kedir H
    BMC Res Notes; 2016 Dec; 9(1):512. PubMed ID: 27998310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.